2024-11-17 21:54:28
Ascentage Pharma Announces First Patient Dosed in the Global Phase Ib/II Clinical Study of Bcl-2 Inhibitor APG-2575 in the United States
Corporate/ 2023-07-23
Ascentage Pharma Announces First Patient...

SUZHOU,China,and ROCKVILLE,Md.,March 23,2020-- Ascentage Pharma (6855.HK),a globally focused,clinical-stage biotechnology company engaged in...

Ascentage Pharma Announces First Patient Dosed in the Global Phase Ib/II Clinical Study of Bcl-2 Inhibitor APG-2575 in the United States
Corporate/ 2023-07-23
Ascentage Pharma Announces First Patient...

SUZHOU,China,and ROCKVILLE,Md.,March 23,2020-- Ascentage Pharma (6855.HK),a globally focused,clinical-stage biotechnology company engaged in...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release